S100B induces the release of pro-inflammatory cytokines in alveolar type I-like cells

International Journal of Immunopathology and Pharmacology

Volumn 26, Issue 2, 2013, Pages 383-391

  Piazza, Ornella ^a   Leggiero, E ^b   De Benedictis, G ^b   Pastore, L ^b   Salvatore, F ^b   Tufano, R ^b   De Robertis, E ^b  

^a UNIVERSITY OF SALERNO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

AT I cells; Pulmonary edema; S100B

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; PROTEIN S100B; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT 1; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT 3; SOLUBLE FORM OF INTERCELLULAR ADHESION MOLECULE 1; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL NUCLEUS; CYTOKINE RELEASE; CYTOKINE RESPONSE; FEMALE; IN VITRO STUDY; INFLAMMATION; LUNG ALVEOLUS CELL TYPE 1; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; CELL STRUCTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOFLUORESCENCE TEST; MALE;

EID: 84881236731     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201302600211     Document Type: Article

References (38)

1. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 2003; 60:540-51.
2. Donato R, Sorci G, Riuzzi F, Arcuri C, Bianchi R, Brozzi F, Tubaro C, Giambanco I. S100B's double life: intracellular regulator and extracellular signal. Biochim Biophys Acta 2009; 1793:1008-22.
3. Sorci G, Bianchi R, Riuzzi F, Tubaro C, Arcuri C, Giambanco I, Donato R. S100B protein, a damaged-associated molecular pattern protein in the brain and hearth, and beyond. Cardiovasc Psychiatry Neurol 2010; doi: 10.1155/2010/656481.
4. Hofmann MA, Drury S, Fu C, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999: 97:889-901. (Pubitemid 29375048)
5. Morbini P, Villa C, Campo I, Zorzetto M, Inghillieri S, Luisetti M. The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? Mod Pathol 2006; 19:1437-45. (Pubitemid 44624162)
6. Sorci G, Giovannini G, Riuzzi F, et al. The danger signal S100B integrates pathogen- and danger-sensing pathways to restrain inflammation. PLoS Pathog 2011; 7 e1001315. doi:10.1371/journal.ppat.1001315.
7. Donato R. RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr Mol Med 2007; 7:711-24.
8. Leclerc E, Fritz G, Vetter SW, Heinzmann CW. Binding of S100 proteins to RAGE: An update. Biochim Biophys Acta 2009; 1793:993-1007.
9. Mukherjee TK, Mukhopadhyay S, Hoidal JR. Implication of receptor for advanced glycation end product (RAGE) in pulmonary health and pathophysiology. Respir Physiol Neurobiol 2008; 162:210-15.
10. Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 2001; 108:949-55. (Pubitemid 32946067)
11. Buckley ST, Ehrhardt C. The receptor for advanced glycation end products (RAGE) and the lung. J Biomed Biotechnol 2010; Doi:10.1155/2010/917108.
12. Maillard-Lefebre H, Boulanger E, Daroux M, Gaxatte C, Hudson BI, Lambert M. Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases. Rheumatology (Oxford) 2009; 48:1190-96.
13. Yan SF, Ramasamy R, Schmidt AM. Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging. Biochem Pharmacol 2010; 79:1379-86.
14. Mauri T, Masson S, Pradella A, et al. Elevated plasma and alveolar levels of soluble receptor for advanced glycation endproducts are associated with severity of lung dysfunction in ARDS patients. Tohoku J Exp Med 2010; 222:105-12.
15. Avlonitis VS, Fisher AJ, Kirby JA, Dark JH. Pulmonary transplantation: the role of brain death in donor lung injury. Transplantation 2003; 75:1928-33. (Pubitemid 36793270)
16. Koslowski R, Barth K, Augstein A, Tschernig T, Bargsten G, Aufderheide M, Kasper M. A new rat type I-like alveolar epithelial cell line R3/1: bleomicin effects on caveolin expression. Histochem Cell Biol 2004; 121:509-19. (Pubitemid 38916439)
17. Dahlin K, Mager EM, Allen L, Tigue Z, Goodglick L, Wadehra M, Dobbs L. Identification of genes differentially expressed in rat alveolar type I cells. Am J Respir Cell Mol Biol 2004; 31:309-16. (Pubitemid 39180300)
18. Fehrenbach H, Kasper M, Tshernig T, Shearman MS, Schulh D, Müller M. Receptor for advanced glycation endproducts (RAGE) exhibits highly differential cellular and subcellular localization in rat and human lungs. Cell Mol Biol 1998; 44:1147-57.
19. McElroy MC, Kasper M. The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair. Eur Respir J 2004;24:664-73. (Pubitemid 39406142)
20. Shirasawa M, Fujiwara N, Hirabayashi S, Ohno H, Iida J, Makita K, Hata Y. Receptor for advanced glycation end products is a marker of type I lung alveolar cells. Genes Cells 2004; 9:165-74. (Pubitemid 38312960)
21. Reynolds PR, Kasteler SD, Cosio MG, Sturrock A, Huecksteadt T, Hoidal JR. RAGE: developmental expression and positive feedback regulation by Egr-1 during cigarette smoke exposure in pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 2008; 294:L1094-1101.
22. Chu WM. Tumor necrosis factor. Cancer Lett 2013; 328:222-25.
23. Rincon M. Interleukin-6: from an inflammatory marker to a target for inflammatory diseases. Trends Immunol 2012; 33:571-75.
24. Baumann A, Audibert G, McDonnell J, Mertes PM. Neurogenic pulmonary edema. Acta Anaesthsiol Scand 2007; 51:447-55. (Pubitemid 46425736)
25. Cobelens PM, Tiebosch IA, Dijkhuizen RM, van der Meide PH, Zwartbol R, Heijnen CJ, Keseciouglu J, van der Bergh WM. Interferon-β attenuates lung inflammation following experimental subarachnoid hemorrhage. Cri tCare 2010; 14:R157. Doi: 10.1186/cc9232.
26. Kalsotra A, Zhao J, Anakk S, Dash PK, Strobel HW. Brain trauma leads to enhanced lung inflammation and injury: evidence for role of P450Fs in resolution. J Cereb Blood Flow Metab 2007; 27:963-74. (Pubitemid 46659024)
27. Piazza O, Cotena S, Esposito G, De Robertis E, Tufano R. S100B is a sensitive but not specific prognostic index in comatose patients after cardiac arrest. Minerva Chir 2005; 60(6):477-80.
28. Bloomfield SM, McKinney J, Smith L, Brisman J. Reliability of S100B in predicting severity of central nervous system injury. Neurocrit Care 2007; 6:121-38. (Pubitemid 46934023)
29. Piazza O, Russo E, Cotena S, Esposito G, Tufano R. Elevated S100B levels do not correlate with the severity of encephalopathy during sepsis. Br J Anaesth. 2007; 99(4):518-21. (Pubitemid 47412494)
30. Pereira AR, Sanchez-Peña P, Biondi A, et al. Predictors of 1-year outcome after coiling for poor-grade subarachnoid aneurismal hemorrhage. Neurocrit Care 2007; 7:18-26. (Pubitemid 350242673)
31. Weiss N, Sanchez-Peña P, Roche S, Beaudeux JL, Colonne C, Coriat P, Puybasset L. Prognosis value of plasma S100B protein levels after subarachnoid aneurismal hemorrhage. Anesthesiology 2006; 104:658-66.
32. Piazza O, Venditto A, Tufano R. Neurogenic pulmonary edema in subarachnoid hemorrage. Panminerva Med 2011; 53:203-10.
33. Calfee CS, Eisner MD, Parsons PE, Thompson BT, Conner ER Jr, Matthay MA, Ware LB, NHLBI Acute Respiratory Distress Syndrome Clinical Trials Network. Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury. Intensive Care Med 2009; 35:248-57.
34. Vanderbilt JN, Mager EM, Allen L, Sawa T, Wiener-Kronish J, Gonzalez R, Dobbs LG. CXC chemokines and their receptor are expressed in type II cells and upregulated following lung injury. Am J Respir Cell Mol Biol 2003; 29:661-68. (Pubitemid 38045934)
35. Ramasamy R, Yan SF, Schmidt AM. RAGE: therapeutic target and biomarker of inflammatory response-the evidence mounts. J Leukoc Biol 2009; 86:505-12.
36. Pietzsch J. S100 proteins in health and disease. Amino Acids 2011; 41:755-60.
37. Pullerits R, Brisslert M, Jonsson IM, Tarkowski A. Soluble receptor for advanced glycation end products triggers a proinflammatory cytokine cascade via β2 integrin Mac-1. Arthritis Rheum 2006; 54:3898-907. (Pubitemid 44955893)
38. Wang Y, Wang H, Piper MG, McMaken S, Mo X, Opalek J, Schmidt AM, Marsh CB. sRAGE induces human monocyte survival and differentiation. J Immunol 2010; 185:1822-35.